Skip to main content
. 2020 Nov 9;9(11):1101. doi: 10.3390/antiox9111101

Figure 4.

Figure 4

Plasmatic SLC23A2 relative expression at baseline. (A) T2DM vs. CG; (B) T2DM + DR vs. T2DM − DR vs. CG. (SLC23A2: Solute Carrier Family 23 Member 2 gene; T2DM: Type 2 diabetes mellitus, +/−DR: With/without diabetic retinopathy, CG: Control group. *: p < 0.05 statistically significant).